Cargando…
Citicoline (Cognizin) in the treatment of cognitive impairment
Pharmacological treatment of cerebrovascular disorders was introduced at the beginning of the 20th Century. Since then, a multitude of studies have focused on the development of a consensus for a well defined taxonomy of these disorders and on the identification of specific patterns of cognitive def...
Autores principales: | Fioravanti, Mario, Buckley, Ann E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695184/ https://www.ncbi.nlm.nih.gov/pubmed/18046877 |
Ejemplares similares
-
Role of Citicoline in Patients With Mild Cognitive Impairment
por: Bermejo, Pedro E, et al.
Publicado: (2023) -
Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study
por: Cotroneo, Antonino Maria, et al.
Publicado: (2013) -
Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications
por: Turana, Yuda, et al.
Publicado: (2021) -
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives
por: Gareri, Pietro, et al.
Publicado: (2015) -
Magnesium Increases the Protective Effect of Citicoline on Aluminum Chloride-induced Cognitive Impairment
por: Hosseini-Sharifabad, Ali, et al.
Publicado: (2020)